High cancer drug prices 4 years later—Progress and prospects

Hagop Kantarjian; Yogin Patel

doi:10.1002/cncr.30545

High cancer drug prices 4 years later—Progress and prospects

Hagop Kantarjian, Yogin Patel

Leukemia

Research output: Contribution to journal › Editorial › peer-review

24 Scopus citations

Original language	English (US)
Pages (from-to)	1292-1297
Number of pages	6
Journal	Cancer
Volume	123
Issue number	8
DOIs	https://doi.org/10.1002/cncr.30545
State	Published - Apr 15 2017

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.30545

Cite this

@article{2e5ab15f306f457188f87e2317aea6c3,

title = "High cancer drug prices 4 years later—Progress and prospects",

author = "Hagop Kantarjian and Yogin Patel",

year = "2017",

month = apr,

day = "15",

doi = "10.1002/cncr.30545",

language = "English (US)",

volume = "123",

pages = "1292--1297",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - High cancer drug prices 4 years later—Progress and prospects

AU - Kantarjian, Hagop

AU - Patel, Yogin

PY - 2017/4/15

Y1 - 2017/4/15

UR - http://www.scopus.com/inward/record.url?scp=85013413457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013413457&partnerID=8YFLogxK

U2 - 10.1002/cncr.30545

DO - 10.1002/cncr.30545

M3 - Editorial

C2 - 28182263

AN - SCOPUS:85013413457

SN - 0008-543X

VL - 123

SP - 1292

EP - 1297

JO - Cancer

JF - Cancer

IS - 8

ER -

High cancer drug prices 4 years later—Progress and prospects

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this